Table 2.

Description and treatment of VAP caused by S. maltophilia

Variables	Total N = 130	Alive at ICU discharge n = 65	Dead at ICU discharge n = 65	p-value
Infection
Bacteremia	4 (3.1)	1 (1.5)	3 (4.6)	0.89
Polymicrobial	58 (44.6)	32 (49.2)	26 (40)	0.29
Duration of mechanical ventilation before onset of VAP, days	12 [5–18]	13.5 [5.5–19]	10 [5–16]	0.62
Treatment
No treatment	38 (29.2)	18 (13.8)	20 (15.4)	0.57
Monotherapy	4 (0.03)	3 (0.02)	1
Combination therapy (≥ 2)	88 (67.7)	44 (67.7)	44 (67.7)
Trimethoprim/sulfamethoxazole	80 (62.5)	40 (62.5)	40 (62.5)	1
Fluoroquinolone	84 (65.6)	40 (62.5)	44 (68.7)	0.46
Ticarcillin–clavulanate	39 (30.4)	20 (31.3)	19 (29.7)	0.85
Ceftazidime	9 (7.0)	5 (7.8)	4 (6.3)	0.99
Duration of appropriate antibiotic therapy, days	8 [5–14]	9[6–14]	7[3–12]	0.12
Time to start of appropriate antibiotic therapy, days	2 [1–3]	2 [1, 2]	2 [1–3]	0.58

Quantitative variables are expressed as median [25–75th percentiles] and qualitative variables as number (%)

VAP ventilator-associated pneumonia, ICU intensive care unit, IQR interquartile range